TETANUS TOXOID (ALUM PRECITITATED)

( ARTG ) Tetanus Immunoglobulin is indicated for the passive protection of individuals who have sustained a tetanus-prone wound and who have either not been actively immunised against tetanus or whose immunisation history is doubtful.​​​‍​​‍​​​​‍​​‍‍ It should also be given to the fully immunised patient with a tetanus-prone wound if more than 10 years have elapsed since the last dose of toxoid. In all the above instances, active immunisation with Tetanus Toxoid, Adsorbed or ADT vaccine should be commenced at the same time [in accordance with details specified in table 1 (Guide to tetanus prophylaxis in wound management) in Indication section of the approved product information provided as Attachment 1]. Although Tetanus Immunoglobulin and vaccine should be given at the same time, they should be administered in opposite limbs, using separate syringes.